Congenital Cardiovascular Shunt Overview

Save information for later
Sign Up

Learn About Congenital Cardiovascular Shunt

What is the definition of Congenital Cardiovascular Shunt?
A cardiovascular shunt is an abnormal pattern of blood circulation between the right and left sides of the heart or between the systemic and pulmonary vessels. A congenital shunt is present at birth. The circulatory system has a normal pathway for blood distribution in which every heart beat provides freshly oxygenated blood to the body. When a shunt is present this normal flow of blood may not occur. There are two main groups of shunts, acyanotic shunts and cyanotic shunts. The most common congenital cardiovascular shunts are acyanotic and known as atrial septal defects. Congenital cardiovascular shunts are the most common congenital heart defects, affecting roughly 1% of all births that have some type of congenital heart problem.
What are the alternative names for Congenital Cardiovascular Shunt?
Intracardiac shunts, right-left shunt, left-right shunt or bidirectional shunt, atrial septal defects, congenital heart defect, congenital heart anomaly
What are the causes of Congenital Cardiovascular Shunt?
A congenital cardiovascular shunt is present at birth and result from abnormal embryo development.
What are the symptoms of Congenital Cardiovascular Shunt?
Symptoms of cardiovascular shunts are dependent on the severity of the abnormal blood flow and the location of the shunt. Sometime the condition is asymptomatic, especially in childhood, although symptoms may appear in adolescence or adulthood. Symptoms of acyanotic shunts: Irregular heartbeats or palpitations Dizziness Shortness of breath and tiring easily Symptoms for more serious cyantonic shunts include: A bluish discoloration of the skin called cyanosis Difficulty breathing Coughing up blood Clubbing of the fingernails or toenails
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Congenital Cardiovascular Shunt?
Treatment depends on the type and location of the shunt and range from clinical observation to surgical intervention. Small acyanotic shunts often do not need treatment and may close on there own over time. Larger acyanotic shunts need to be closed surgically to avoid complications. Cyanotic shunts, which are more serious and have a higher rate of mortality, often require surgery to correct the defect.
Who are the top Congenital Cardiovascular Shunt Local Doctors?
Maurice Beghetti
Elite in Congenital Cardiovascular Shunt
Maurice Beghetti
Elite in Congenital Cardiovascular Shunt
Maurice Beghetti
Geneve, GE, CH 

Maurice Beghetti practices in Geneve, Switzerland. Mr. Beghetti is rated as an Elite expert by MediFind in the treatment of Congenital Cardiovascular Shunt. His top areas of expertise are Congenital Cardiovascular Shunt, Pulmonary Hypertension, Hypertension, Embolectomy, and Lung Transplant.

Elite in Congenital Cardiovascular Shunt
Dr. Andrew C. Glatz
Pediatric Cardiology | Pediatrics | Cardiology
Elite in Congenital Cardiovascular Shunt
Dr. Andrew C. Glatz
Pediatric Cardiology | Pediatrics | Cardiology

Washington University

1 Childrens Pl, 
Saint Louis, MO 
314-273-1006
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Andrew Glatz is a Pediatric Cardiologist and a Pediatrics provider in Saint Louis, Missouri. Dr. Glatz is rated as an Elite provider by MediFind in the treatment of Congenital Cardiovascular Shunt. His top areas of expertise are Pulmonary Atresia with Intact Ventricular Septum, Pulmonary Atresia, Tetralogy of Fallot, Stent Placement, and Angioplasty. Dr. Glatz is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Congenital Cardiovascular Shunt
Peter Ewert
Elite in Congenital Cardiovascular Shunt
Peter Ewert
Ismaninger Str. 22, 
Munich, BY, DE 

Peter Ewert practices in Munich, Germany. Mr. Ewert is rated as an Elite expert by MediFind in the treatment of Congenital Cardiovascular Shunt. His top areas of expertise are Congenital Heart Disease (CHD), Congenital Cardiovascular Shunt, Tetralogy of Fallot, Stent Placement, and Heart Transplant.

View All Doctors
What is the outlook (prognosis) for Congenital Cardiovascular Shunt?
In all cases of congenital cardiovascular shunts close observation and timely intervention are critical. The prognosis ranges from living a normal life to potentially fatal. Acyanotic shunts are less serious than cyanotic shunts and often close on their own over time. Larger ones may require surgery to repair, but if proper treatment is undertaken before the onset of serious symptoms the prognosis for recovery is good. Cyanotic shunts and untreated symptomatic acyanotic shunts have a worse prognosis. If severe pulmonary hypertension develops or if there is permanent damage to the blood vessels in the lungs a heart or lung transplant may be necessary. When severe cyanotic anomalies are present soon after birth immediate surgery is needed in order to increase the chance of survival.
What are the possible complications of Congenital Cardiovascular Shunt?
Most shunts are benign and do not cause complications. In severe cases of cyanotic shunts possible complications can be recurrent infections, pulmonary hypertension, right side heart failure, Eisenmenger syndrome, infections in the heart valves or linings of the heart and disturbances in the heart rhythm. Death is possible in severe cases.
What are the latest Congenital Cardiovascular Shunt Clinical Trials?
Prospective, Monocentric Pilot Study for the Identification of Known or Novel Genes Associated With Development of Pulmonary Arterial Hypertension in Patients With Congenital Shunt Lesions
Prospective, Monocentric Pilot Study for the Identification of Known or Novel Genes Associated With Development of Pulmonary Arterial Hypertension in Patients With Congenital Shunt Lesions
Enrollment Status: Recruiting
Publish Date: March 28, 2025
Intervention Type: Other
Study Phase: Not Applicable

Summary: Pulmonary arterial hypertension (PAH) in patients with congenital heart disease (CHD) is associated with considerable morbidity and even mortality. Next to environmental risk factors, the investigators believe that there is an important role of genetic predisposition to develop PAH in CHD. There often is a discrepancy between the severity of PAH and the CHD, where it is useful to screen for PAH ge...

Match to trials
Find the right clinical trials for you in under a minute
Get started
The Role of Thiamine on Left Ventricular Structure and Function After Transcatheter Closure Through the Examination of MMP-9 Dan TIMP-1 in Children With Left-to-Right Shunt Congenital Heart Disease
The Role of Thiamine on Left Ventricular Structure and Function After Transcatheter Closure Through the Examination of MMP-9 Dan TIMP-1 in Children With Left-to-Right Shunt Congenital Heart Disease
Enrollment Status: Recruiting
Publish Date: May 08, 2024
Intervention Type: Drug
Study Phase: Early Phase 1

Summary: Currently, research on the effect of thiamine administration during transcatheter closure on the structure and function of the left ventricle by examining levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in children with left to right shunt congenital heart disease has never been carried out in Indonesia, so it is necessary carried out this research. This research w...

View All Clinical Trials